Improved Cardiovascular Effects of a Novel Pomegranate Byproduct Extract Obtained through Hydrodynamic Cavitation
Authors:
- Giada BenedettiGBGiada Benedetti
- Lorenzo FloriLFLorenzo Flori
- Jacopo SpezziniJSJacopo Spezzini
- Vincenzo MiragliottaVMVincenzo Miragliotta
- Giulia LazzariniGLGiulia Lazzarini
- Andrea PironeAPAndrea Pirone
- Cosimo MeneguzzoCMCosimo Meneguzzo
- Luca TagliaventoLuca Tagliavento
- Alma MartelliAlma Martelli
- Michele AntonelliMichele Antonelli
- Davide DonelliDavide Donelli
- Cecilia FaraloniCFCecilia Faraloni
Open Access
Abstract
The healthy properties of pomegranate fruit, a highly consumed food, have been known for a long time. However, the pomegranate supply chain is still rather inefficient, with the non-edible fraction, whose weight is roughly half the total and is endowed with plenty of valuable bioactive compounds, either disposed of or underutilized. A novel extract obtained from non-edible byproducts (called PPE), using hydrodynamic cavitation, a green, efficient, and scalable technique, was investigated for its cardiovascular effects in vivo. PPE showed efficacy in an acute phenylephrine (PE)-induced hypertensive rat model, similar to the extract of whole fruit (PFE) obtained using the same extractive technique, along with good intestinal bioaccessibility after oral administration. Finally, when chronically administered for 6 weeks to spontaneously hypertensive rats, PPE was shown to significantly contain the increase in systolic blood pressure, comparable to the reference drug Captopril, and at a dose remarkably lower than the reported effective dose of ellagic acid. The extract from the non-edible fraction of the pomegranate fruit also showed good anti-inflammation and anti-fibrotic effects. The findings of this study, along with the extraction technique, could contribute to enhancing the value of the pomegranate supply chain, relieve the related environmental burden, and potentially improve public health.Keywords
Funding Information
- PNRR (National Recovery and Resilience Plan)—Mission 4 (PE0000003, FOE-2021 DBA.AD005.225, CUP I53C22001240005)
- European Union NextGenerationEU (PE0000003, FOE-2021 DBA.AD005.225, CUP I53C22001240005)
- CNR project “NUTRAGE” (PE0000003, FOE-2021 DBA.AD005.225, CUP I53C22001240005)
- Institutional Collaboration between Department of Pharmacy and Institute of Bioeconomy of CNR (PE0000003, FOE-2021 DBA.AD005.225, CUP I53C22001240005)
This publication has 56 references indexed in Scilit:
- Medicinal uses, pharmacological activities, phytochemistry, and the molecular mechanisms of Punica granatum L. (pomegranate) plant extracts: A reviewBiomedicine & Pharmacotherapy, 2022
- Physical formulation approaches for improving aqueous solubility and bioavailability of ellagic acid: A reviewEuropean Journal of Pharmaceutics and Biopharmaceutics, 2021
- Punicalagin, a Pomegranate‐Derived Ellagitannin, Suppresses Obesity and Obesity‐Induced Inflammatory Responses Via the Nrf2/Keap1 Signaling PathwayMolecular Nutrition & Food Research, 2019
- Endothelial Dysfunction and Hypertension2016
- Stability and solubility enhancement of ellagic acid in cellulose ester solid dispersionsCarbohydrate Polymers, 2013
- Comparison of antioxidant activities of juice, peel, and seed of pomegranate (Punica granatum L.) and inter-relationships with total phenolic, Tannin, anthocyanin, and flavonoid contentsFood Science and Biotechnology, 2012
- Endothelium, aging, and hypertensionCurrent Hypertension Reports, 2006
- Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juiceClinica Chimica Acta, 2004
- Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juiceEuropean Journal of Nutrition, 2003
- Effects of triiodothyronine in spontaneously hypertensive rats. Studies on cardiac metabolism, function, and heart weightBasic Research in Cardiology, 1992